Fairvalue-Calculator Fairvalue-Calculator
EN DE

Centrum Medyczne ENEL-MED S.A (ENE) Fair Value & Analysis

Healthcare · PL · Market cap 537M PLN

Price19.20 PLN
Fair Value10.03 PLN
Upside-47.8%
Quality95/100
Evidence: High Range 7.52 PLN – 12.54 PLN

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Centrum Medyczne ENEL-MED S.A (ENE) currently trades at 19.20 PLN, while our model-based Fair Value estimate is 10.03 PLN — implying the stock looks roughly 47.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Centrum Medyczne ENEL-MED S.A., together with its subsidiaries, operates hospitals in Poland, Austria, France, the United Kingdom, and internationally. It offers various medical services comprising pediatric specialist consultations, dentistry, orthopedic, infertility treatment, rehabilitation, psychological, imaging and diagnostics, laboratory diagnostics, and emergency care services. The company also provides vaccination services for adult and children. Centrum Medyczne ENEL-MED S.A. was founded in 1993 and is headquartered in Warsaw, Poland.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Centrum Medyczne ENEL-MED S.A (ENE) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 10.03 PLN versus a price of 19.20 PLN — about −48% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ENE?
Our 21-model fair value for Centrum Medyczne ENEL-MED S.A is 10.03 PLN (as of Jun 24, 2026), built from audited fundamentals. The current price is 19.20 PLN.
What is the quality score of ENE?
Centrum Medyczne ENEL-MED S.A has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.